Shoufeng Li,

CEO

Dr. Li is a Scientist and Founder of the company.  With 20 years of global pharmaceutical industry experience, he is responsible for the overall strategy, direction, and growth of the business. 

Before founding Aucta, Dr. Li held management roles at Novartis Pharmaceuticals and Eon Labs (Sandoz). 

Dr. Li holds a Ph.D. in Pharmaceutics and an M.S. in Statistics.

Brian Zorn,

Pharm D, Consultant, Commercial Development

With over 26 years of pharmaceutical industry experience, including new product planning, marketing, medical communications and sales, and extensive experience in providing market/product assessments, Mr. Zorn is responsible for the commercial direction of the company.

Mr. Zorn played a key role in the launch and marketing of leading brands, including Omnicef®, Neurontin®, Lyrica® and Diovan®.

Mr. Zorn holds a Doctor of Pharmacy.

Qiaolin Ren,

VP, R&D and Manufacture

With over 15 years of pharmaceutical industry experience, Dr. Ren is responsible for portfolio and pipeline development and management. He has extensive experience in formulation design, process development, technical transfers and manufacturing, and he previously held roles at Novartis, Sandoz, Fougera and Amylin. Dr. Ren holds a Ph.D. in Industrial Pharmacy.

Lixin Gong,

Executive Director, Analytical Development

With 18 years of pharmaceutical industry experience, Ms. Gong is responsible for analytical development, quality management, and regulatory affairs. She has in-depth knowledge and experience of analytical method development and validation and a solid understanding of quality systems and GMP/ GLP/FDA/ICH and DEA regulations. Prior to joining Aucta, she held roles of increasing responsibility with West-Ward, Alpharma, and BMS. Ms. Gong holds a B.S. in Organic Chemistry and an M.S. in Analytical Chemistry.